|
The Immunohistochemistry Antibody Company
|
|
|
Skin Cancer Screen 24 Tissue Microarray - LS-SSKCA24This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SSKCA24 |
| Product Name: | Skin Cancer Screen 24 |
| Description: | Skin cancer with corresponding (unmatched)adjacent normal/non-neoplastic skin |
| Format: | FFPE |
| Category: | Human Tumor and Adjacent Normal |
| QA/QC: | H&E reviewed; IHC validated with a positive control antibody |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | Yes |
| Core Diameter: | 1.5 mm |
| Core Thickness: | 5 µm |
| Cases: | 24 |
| Cores: | 48 |
| Slides Per Set: | 1 |
LS-SSKCA24 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Skin (Skn); Skin, Back (Skn); Skin, Breast (Skn); Skin, Cheek (Skn); Skin, Eyelid (Skn); Skin, Face (Skn); Skin, Foot sole (Skn); Skin, Hand (Skn); Skin, Head (Skn); Skin, Nose (Skn); Skin, Scalp (Skn); Skin, Shoulder (Skn); Skin, Thigh (Skn); Skin, Vulva (Skn);
LS-SSKCA24 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | Tumor Grade |
|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | M | 68 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | A2 | Human | M | 68 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | A3 | Human | F | 62 y | Skin, Foot sole (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | A4 | Human | F | 62 y | Skin, Foot sole (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | A5 | Human | M | 64 y | Skin, Thigh (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | A6 | Human | M | 64 y | Skin, Thigh (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | A7 | Human | F | 64 y | Skin, Vulva (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | A8 | Human | F | 64 y | Skin, Vulva (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | B1 | Human | F | 74 y | Skin, Cheek (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | B2 | Human | F | 74 y | Skin, Cheek (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | B3 | Human | M | 36 y | Skin, Back (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | B4 | Human | M | 36 y | Skin, Back (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | B5 | Human | F | 48 y | Skin, Scalp (Skn) | Squamous cell carcinoma | Malignant | 2 |
| 1 | B6 | Human | F | 48 y | Skin, Scalp (Skn) | Squamous cell carcinoma | Malignant | 2 |
| 1 | B7 | Human | F | 43 y | Skin, Breast (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | B8 | Human | F | 43 y | Skin, Breast (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | C1 | Human | F | 65 y | Skin, Face (Skn) | Squamous cell carcinoma | Malignant | 2 |
| 1 | C2 | Human | F | 65 y | Skin, Face (Skn) | Squamous cell carcinoma | Malignant | 2 |
| 1 | C3 | Human | F | 69 y | Skin, Breast (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | C4 | Human | F | 69 y | Skin, Breast (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | C5 | Human | F | 82 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | 2 |
| 1 | C6 | Human | F | 82 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | 1 |
| 1 | C7 | Human | F | 80 y | Skin, Scalp (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | C8 | Human | F | 80 y | Skin, Scalp (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | D1 | Human | F | 57 y | Skin, Eyelid (Skn) | Basal cell carcinoma | Malignant | |
| 1 | D2 | Human | F | 57 y | Skin, Eyelid (Skn) | Basal cell carcinoma | Malignant | |
| 1 | D3 | Human | F | 75 y | Skin, Hand (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | D4 | Human | F | 75 y | Skin, Hand (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | D5 | Human | M | 60 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant | |
| 1 | D6 | Human | M | 60 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant | |
| 1 | D7 | Human | M | 16 y | Skin, Shoulder (Skn) | Adjacent normal with intradermal nevus | Benign non-neoplastic | |
| 1 | D8 | Human | M | 16 y | Skin, Shoulder (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | E1 | Human | M | 44 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E2 | Human | M | 44 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E3 | Human | F | 50 y | Skin, Breast (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | E4 | Human | F | 50 y | Skin, Breast (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | E5 | Human | M | 63 y | Skin, Nose (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E6 | Human | M | 63 y | Skin, Nose (Skn) | Basal cell carcinoma | Malignant | |
| 1 | E7 | Human | F | 42 y | Skin, Breast (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | E8 | Human | F | 42 y | Skin, Breast (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | F1 | Human | M | 71 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant | |
| 1 | F2 | Human | M | 71 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant | |
| 1 | F3 | Human | M | 69 y | Skin, Hand (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | F4 | Human | M | 69 y | Skin, Hand (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | F5 | Human | M | 38 y | Skin (Skn) | Basal cell carcinoma | Malignant | |
| 1 | F6 | Human | M | 38 y | Skin (Skn) | Basal cell carcinoma | Malignant | |
| 1 | F7 | Human | F | 49 y | Skin, Breast (Skn) | Adjacent normal | Benign non-neoplastic | |
| 1 | F8 | Human | F | 49 y | Skin, Breast (Skn) | Adjacent normal | Benign non-neoplastic |